![]() |
市場調查報告書
商品編碼
1729238
全球 CBD 寵物市場規模研究,按動物類型(狗、貓)、適應症(關節疼痛、焦慮/壓力、癲癇)、配銷通路(寵物專賣店、電子商務、CBD 商店)和區域預測 2022-2032Global CBD Pet Market Size study, by Animal Type (Dogs, Cats), Indication (Joint Pain, Anxiety/Stress, Epilepsy), Distribution Channel (Pet Specialty Stores, E-commerce, CBD Store), and Regional Forecasts 2022-2032 |
2023 年全球 CBD 寵物市場價值約為 30.1 億美元,預計在 2024-2032 年預測期內將以超過 32.47% 的驚人年複合成長率成長。隨著現代寵物主人擴大為他們的寵物尋求整體和替代的健康療法,CBD 寵物市場迅速獲得發展勢頭,從小眾新奇事物轉變為主流必需品。大麻二酚 (CBD) 是一種從大麻中提取的非精神活性化合物,目前被用作治療一系列寵物健康問題的治療劑,從關節活動和慢性疼痛到行為障礙和神經失衡。隨著對寵物福祉、人類級標準和產品透明度的重視程度不斷提高,市場正在演變成一個充滿創新和功能性產品開發的受監管生態系統。
寵物收養率的激增,加上人們對寵物健康意識的提高,加劇了對天然補充品的需求,尤其是千禧世代和 Z 世代的寵物父母。含有 CBD 的零食、油、酊劑和外用藥因其安全性和極小的副作用而受到消費者的極大歡迎。此外,寵物因壓力而產生的疾病(如分離焦慮和與年齡相關的關節炎)的發病率不斷上升,促使寵物主人積極採用 CBD 配方進行預防性護理。產業參與者正在透過制定針對特定物種、針對特定條件且有研究支持的產品來策略性地實現其產品的差異化,同時也整合2D碼透明度和第三方測試來建立消費者信任。
儘管市場呈現爆炸性成長,但仍面臨監管模糊性,特別是在標籤、劑量一致性和州際貿易方面,這些仍然是突出的障礙。此外,有限的長期臨床資料,加上不同程度的獸醫認可,繼續影響某些族群的消費者猶豫。此外,優質 CBD 寵物產品的高成本可能會限制價格敏感地區的採用。儘管如此,隨著科學共識的加強和聯邦框架朝著更清晰的指導方針發展,利益相關者的信心預計將大幅提升,從而鞏固 CBD 作為傳統獸醫治療可靠輔助手段的地位。
影響市場的另一個動態是寵物護理零售的數位化。電子商務平台和直接面對消費者的品牌正在利用資料分析、個人化推薦引擎和社群媒體行銷來培養忠實的客戶群。訂閱式服務和精選的 CBD 健康盒也正在取得進展,在為寵物主人提供便利和連續性的同時,創造了經常性的收入來源。從大麻來源追蹤到2D碼實驗室結果訪問,產品透明度正在成為吸引注重健康的消費者的關鍵品牌差異化因素。這種數位化方法在城市市場中尤其重要,因為便利性通常決定購買行為。
從地區來看,受美國完善的 CBD 法律框架和日益成長的寵物人性化趨勢的推動,北美在 2023 年佔據了 CBD 寵物市場主導地位。歐洲緊隨其後,德國、英國和荷蘭等國家逐漸放寬 CBD 法規並採用天然的寵物健康解決方案。同時,亞太地區正成為一個利潤豐厚的前沿市場,尤其是在日本、韓國和澳洲等國家,寵物替代療法在這些國家越來越受到文化的認可。儘管拉丁美洲和中東及非洲的監管仍處於起步階段,但隨著 CBD 意識、獸醫教育和零售基礎設施的擴展,預計這些地區將會開放。
Global CBD Pet Market is valued approximately at USD 3.01 billion in 2023 and is anticipated to grow with an astonishing compound annual growth rate of more than 32.47% over the forecast period 2024-2032. As modern pet owners increasingly seek holistic and alternative wellness remedies for their companions, the CBD pet market has rapidly gained momentum, transforming from niche novelty to mainstream necessity. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, is now being embraced as a therapeutic agent across a spectrum of pet health concerns-from joint mobility and chronic pain to behavioral disorders and neurological imbalances. With heightened emphasis on pet well-being, human-grade standards, and product transparency, the market is evolving into a regulated ecosystem teeming with innovation and functional product development.
The surge in pet adoption rates, coupled with heightened awareness about pet health, has intensified demand for natural supplements, especially among millennial and Gen Z pet parents. CBD-infused treats, oils, tinctures, and topicals are witnessing remarkable consumer traction due to their perceived safety profile and minimal side effects. Furthermore, increasing incidences of stress-induced conditions, such as separation anxiety and age-related arthritis in pets, are propelling owners to proactively adopt preventative care using CBD formulations. Industry players are strategically differentiating their offerings by formulating species-specific, condition-targeted products backed by research, while also integrating QR-coded transparency and third-party testing to build consumer trust.
Despite its explosive growth, the market faces regulatory ambiguities, especially surrounding labeling, dosage consistency, and inter-state commerce, which remain prominent barriers. Additionally, limited long-term clinical data, combined with varying degrees of veterinarian endorsement, continues to influence consumer hesitancy in certain demographics. Moreover, the high cost of premium CBD pet products may restrict adoption in price-sensitive regions. Nevertheless, as scientific consensus strengthens and federal frameworks evolve toward clearer guidelines, stakeholder confidence is expected to surge, reinforcing CBD's standing as a reliable adjunct to conventional veterinary treatment.
Another dynamic shaping the market is the digitalization of pet care retail. E-commerce platforms and direct-to-consumer brands are leveraging data analytics, personalized recommendation engines, and social media marketing to foster loyal customer bases. Subscription-based services and curated CBD wellness boxes are also making inroads, creating recurring revenue streams while offering pet parents convenience and continuity. From hemp-sourced origin tracking to QR-enabled lab result access, product transparency is becoming a key brand differentiator that appeals to health-conscious consumers. This digitized approach is particularly crucial in urban markets, where convenience often dictates purchase behavior.
Regionally, North America dominated the CBD pet market in 2023, buoyed by an established CBD legal framework in the U.S. and growing pet humanization trends. Europe is not far behind, with nations like Germany, the UK, and the Netherlands gradually liberalizing CBD regulations and embracing natural pet wellness solutions. Meanwhile, the Asia Pacific region is emerging as a lucrative frontier, especially in countries like Japan, South Korea, and Australia, where alternative therapies for pets are gaining cultural acceptance. Latin America and the Middle East & Africa, though nascent in regulatory maturity, are anticipated to open up as CBD awareness, veterinary education, and retail infrastructure expand.